Around 20% of pancreatic cancers are in the normal range for CA-19-9 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351346/) with 1/2 of those patients being Le negative, meaning the body can't manu..

... here are some altenative ideas we researched that you can discuss with his medical team or other doctors via a second opinion...

I appreciate your fear of a rising CA-19-9 during remission and agree that now would be a very good time to either have 1) Next Gen Sequencing of the ORIGINAL tumor (if not done previously)...

... a very interesting innovative approach being offered at West Virginia University Medicine in Morgantown, studying a new device to administer the gemcitabine (mentioned above) directly to ...